David B Wyck

David B Van Wyck

UNVERIFIED PROFILE

Are you David B Van Wyck?   Register this Author

Register author
David B Wyck

David B Van Wyck

Publications by authors named "David B Van Wyck"

14Publications

228Reads

46Profile Views

1PubMed Central Citations

Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis.

Am J Kidney Dis 2010 Sep 16;56(3):540-6. Epub 2010 Jul 16.

DaVita Inc, Denver, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2010.05.009DOI Listing
September 2010

Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.

Obstet Gynecol 2007 Aug;110(2 Pt 1):267-78

Arizona Health Sciences Center, University of Arizona College of Medicine, 1821 East Elm Street, Tucson, AZ 85719, USA.

View Article

Download full-text PDF

Source
http://www.coaching-for-health.net/eisenzentrum/studien/Feri
Web Search
http://dx.doi.org/10.1097/01.AOG.0000275286.03283.18DOI Listing
August 2007

Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.

Clin J Am Soc Nephrol 2006 May 29;1(3):475-82. Epub 2006 Mar 29.

Western Nephrology & Metabolic Bone Disease, PC, Lakewood, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.01541005DOI Listing
May 2006

A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.

Kidney Int 2005 Dec;68(6):2846-56

University of Arizona College of Medicine, Tucson, AZ 85704-6128, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1523-1755.2005.00758.xDOI Listing
December 2005

Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients.

Nephrol Dial Transplant 2005 Jul 19;20(7):1438-42. Epub 2005 Apr 19.

Division of Nephrology and Hypertension, University of Miami School of Medicine, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfh811DOI Listing
July 2005

Labile iron: manifestations and clinical implications.

Authors:
David B Van Wyck

J Am Soc Nephrol 2004 Dec;15 Suppl 2:S107-11

Department of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ASN.0000143816.04446.4CDOI Listing
December 2004

Making sense: a scientific approach to intravenous iron therapy.

J Am Soc Nephrol 2004 Dec;15 Suppl 2:S91-2

Department of Medicine and Surgery, University of Arizona College of Medicine, Tucson, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ASN.0000143813.03529.ECDOI Listing
December 2004

Error, not iron, generates cytotoxicity.

Authors:
David B Van Wyck

Am J Kidney Dis 2002 Nov;40(5):1109-10; author reply 1110

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/ajkd.2002.37033DOI Listing
November 2002

Just the FAQs: frequently asked questions about iron and anemia in patients with chronic kidney disease.

Am J Kidney Dis 2002 Feb;39(2):426-32

Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S027263860211960
Publisher Site
http://dx.doi.org/10.1053/ajkd.2002.30566DOI Listing
February 2002